Medigen Vaccine Biologics (ROCO:6547) Dividends per Share : NT$0.00 (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics Dividends per Share?

Medigen Vaccine Biologics's dividends per share for the three months ended in Mar. 2025 was NT$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Medigen Vaccine Biologics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Medigen Vaccine Biologics Dividends per Share Historical Data

The historical data trend for Medigen Vaccine Biologics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Vaccine Biologics Dividends per Share Chart

Medigen Vaccine Biologics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividends per Share

Get a 7-Day Free Trial

Medigen Vaccine Biologics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medigen Vaccine Biologics's Dividends per Share

For the Biotechnology subindustry, Medigen Vaccine Biologics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Vaccine Biologics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Medigen Vaccine Biologics Dividends per Share Calculation

Dividends paid to per common share.

Medigen Vaccine Biologics (ROCO:6547) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Medigen Vaccine Biologics's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	-0.06
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Medigen Vaccine Biologics Dividends per Share Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Vaccine Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261

Website

https://www.medigenvac.com

Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of COVID-19 vaccines and COVID-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines